Hepatitis B and C in dialysis units in Kosova

被引:23
作者
Telaku, Skender [1 ]
Fejza, Hajrullah [2 ]
Elezi, Ymer [3 ]
Bicaj, Teuta [4 ]
机构
[1] Univ Clin Ctr Kosova, Gastroenterol Unit, Prishtina, Serbia
[2] Municipal Prishtina, Sector Publ Hlth, Prishtina, Serbia
[3] Univ Clin Ctr Kosova, Nephrol Unit, Prishtina, Serbia
[4] Univ Dent Clin Ctr Kosova, Dept Prosthet Dent, Prishtina, Serbia
关键词
VIRUS-INFECTION; HEMODIALYSIS-PATIENTS; HCV INFECTION; RISK-FACTORS; FOLLOW-UP; PREVALENCE; MULTICENTER; ASSAY; TRANSMISSION; PATIENT;
D O I
10.1186/1743-422X-6-72
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. This study aimed to investigate the epidemiological and clinical features of HCV and HBV infections in six different HD units in Kosova. Five hundred and eighty-three end-stage kidney disease (ESKD) patients on maintenance HD from six HD centers in Kosova (358 female, 225 male, mean age 54,8 years (16-66) were included in this study. Data from databank of the National Blood Bank in Prishtina, as well as the data from the databank of the Transfusion Centers in Regional hospitals in Prizren, Peja, Gjilan, Mitrovica and Gjakova were taken in this study. Clinical data such as age, sex, HBsAg and anti-HCV antibody and primary causes of ESKD were examined. Serological markers for HBV and HCV were determined with immunoenzymatic assay (ELISA). Results: The T-test and x(2) test were used to analyze the significance of the results. Among our HD patients HBsAg and anti-HCV antibody prevalence rate was 12%, respectively 43%. Chronic nephritis was a more frequent cause of ESKD among our HD patients. With unknown etiology were 23, 5% from them. Conclusion: HBV and HCV prevalence in our HD patients is still high. These data emphasize the need for stricter adherence to infection control, barrier precaution and preventive behaviors with all patients.
引用
收藏
页数:4
相关论文
共 48 条
[1]  
Ahmedou MO, 2006, ADV NONLINEAR STUD, V6, P13
[2]   Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients [J].
Alavian, SM ;
Einollahi, B ;
Hajarizadeh, B ;
Bakhtiari, S ;
Nafar, M ;
Ahrabi, S .
NEPHROLOGY, 2003, 8 (05) :256-260
[3]   Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients.: A long-term follow up (1989-january 1997) [J].
Almroth, G ;
Ekermo, B ;
Månsson, AS ;
Svensson, G ;
Widell, A .
JOURNAL OF INTERNAL MEDICINE, 2002, 251 (02) :119-128
[4]  
Boulaajaj Kawtar, 2005, Nephrol Ther, V1, P274, DOI 10.1016/j.nephro.2005.06.012
[5]   Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients [J].
Bouzgarrou, N ;
Fodha, I ;
Ben Othman, S ;
Achour, A ;
Grattard, F ;
Trabelsi, A ;
Pozzetto, B .
JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (04) :502-508
[6]   Renal replacement therapy in Slovenia: annual report 2001 [J].
Buturovic-Ponikvar, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 :53-55
[7]  
Chattopadhyay Saket, 2005, Hemodial Int, V9, P362, DOI 10.1111/j.1542-4758.2005.01154.x
[8]  
Chen KS, 1996, NEPHRON, V73, P158
[9]  
Chironna M, 2001, Int J Infect Dis, V5, P209, DOI 10.1016/S1201-9712(01)90073-6
[10]   Hepatitis virus infection in haemodialysis patients from Moldavia [J].
Covic, A ;
Iancu, L ;
Apetrei, C ;
Scripcaru, D ;
Volovat, C ;
Mititiuc, I ;
Covic, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) :40-45